European Healthtech startup funding raised during May 2026.
In May 2026, 33 European Healthtech companies raised a combined €2.0B across 33 funding rounds, up 174.5% versus May 2025. UK led by capital raised, and Qantx was the most active investor. Data as of 9 Jul 2026.
3 exits.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Series B | May 2026 | €1.8B |
| Uromems | Growth/Late | May 2026 | €52M |
| NVision Imaging | Series B | May 2026 | €47M |
| NUCLIDIUM | Series B |
| May 2026 |
| €29M |
| EnteroBiotix | Other | May 2026 | €22M |
| Lucis | Series A | May 2026 | €17M |
| BioCopy | Series A | May 2026 | €9.8M |
| Ditto | Other | May 2026 | €7.6M |
| Cellply | Other | May 2026 | €7.2M |
| Neurosoft Bioelectronics | Seed | May 2026 | €6.5M |
| Imperagen | Seed | May 2026 | €5.8M |
| iFAST Diagnostics | Other | May 2026 | €5.8M |
| ReVision Implant | Other | May 2026 | €4.0M |
| QuberTech | Other | May 2026 | €3.9M |
| Sedivention | Seed | May 2026 | €2.9M |
